ESR1 and breast carcinoma: Oncotype DX uses expression values of 16 genes, which are normalized relative to the expression values a set of 5 housekeeping genes, to compute an RS to predict the risk of distant recurrence of estrogen receptor-positive (ER+) breast cancer patients [8, 32].